Sendero Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.18M Buy
8,918
+40
+0.5% +$9.32K 0.24% 65
2025
Q4
$1.84M Buy
8,878
+113
+1% +$22.3K 0.2% 72
2025
Q3
$1.63M Buy
8,765
+412
+5% +$70.6K 0.19% 74
2025
Q2
$1.28M Buy
8,353
+337
+4% +$51.8K 0.16% 83
2025
Q1
$1.33M Buy
8,016
+1,040
+15% +$163K 0.18% 75
2024
Q4
$1.01M Hold
6,976
0.15% 85
2024
Q3
$1.13M Hold
6,976
0.18% 74
2024
Q2
$1.02M Sell
6,976
-779
-10% -$116K 0.17% 75
2024
Q1
$1.23M Buy
7,755
+386
+5% +$61.4K 0.21% 71
2023
Q4
$1.16M Buy
7,369
+155
+2% +$23.8K 0.22% 73
2023
Q3
$1.12M Hold
7,214
0.24% 72
2023
Q2
$1.19M Buy
+7,214
New +$1.16M 0.26% 71

Other funds holding JNJ

Sendero Wealth Management's JNJ Position: Q1 2026 in Review

Sendero Wealth Management increased its Johnson & Johnson (JNJ) stake by 0.45% in Q1 2026, buying an estimated $9.32K and bringing the position to 8,918 shares worth $2.18M. The position accounts for 0.24% of the portfolio, ranked #65.

Sendero Wealth Management first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Sendero Wealth Management held 8,918 shares of Johnson & Johnson worth $2.18M as of Q1 2026.
  • Sendero Wealth Management bought 40 Johnson & Johnson shares in Q1 2026, an estimated $9.32K.
  • Johnson & Johnson made up 0.24% of Sendero Wealth Management's portfolio in Q1 2026, its #65 holding.
  • Sendero Wealth Management first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Sendero Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.